Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julia Madani
Observed names:
J. Madani,
Jad Madani
Institutions:
University of California, Los Angeles,
Hospital Clínico Universitario Lozano Blesa
Observed institutions:
University of California, Los Angeles,
Hospital Universitario Miguel Servet,
Hospital Clínico Universitario Lozano Blesa,
Hospital Universitario de Valme,
Instituto Aragonés de Ciencias de la Salud,
Hospital General San Jorge
show all 6
ORCID:
0009-0009-9908-063X
Observed ORCID:
0009-0009-9908-063X
OpenAlex ID:
A5011361309
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
2013
·
Juan Lao
, Julia Madani
, et al.
·
Journal of Drug Delivery
·
214
PDF
Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma
2010
·
Javier Martinez-Trufero
, Jorge Alfaro
, et al.
·
Anti-Cancer Drugs
·
17
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study
2022
·
Alfonso Yubero
, Aranzazu Barquín
, et al.
·
BMC Cancer
·
11
Bevacizumab (BVZ) as second-line treatment after sorafenib (SFB) progression in patients (pts) with advanced hepatocellular carcinoma (HCC).
2010
·
R. A. Pazo Cid
, G. Esquerdo
, et al.
·
Journal of Clinical Oncology
·
7
Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO.
2022
·
Alfonso Yubero-Esteban
, Piedad Reche-Molina
, et al.
·
Journal of Clinical Oncology
·
1
403 Analysis of the clinical experience within rucaparib’s early access program in Spain – a GEICO study
2021
·
A. Yubero-Esteban
, A. Barquin
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
Structural and Vascular Findings in Autologous Retinal Transplantation for Macular Hole
2026
·
Jad Madani
, Rami Madani
, et al.
·
Journal of VitreoRetinal Diseases
102P Evaluation of the efficacy of dose-adjusted fluoropyrimidine-based treatment in patients with metastatic colorectal cancer carrying DPYD polymorphisms
2026
·
S. Campos Ramirez
, M. Alvarez Alejandro
, et al.
·
Annals of Oncology
2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO
2022
·
Alfonso Yubero
, Aranzazu Barquín
, et al.
·
International Journal of Gynecological Cancer
PDF
Clinical insights from the rucaparib access program in Spain: A sub-analysis of long-term responders by GEICO.
2022
·
Alfonso Yubero-Esteban
, Arantzazu Barquin
, et al.
·
Journal of Clinical Oncology
Prognostic models in advanced gastric cancer in first and second line chemotherapy treatment in Spanish population.
2017
·
Jorge Hernando-Cubero
, Natalia Alvarez-Garcia
, et al.
·
Journal of Clinical Oncology
Impact of vascular endothelial growth factor (VEGF) and hypoxia-inductible factor-1 alpha (HIF-1) expression on the prognosis of locally advanced cervical carcinoma (LACC) treated with radiochemotherapy.
2017
·
Julia Madani
, Beatriz Eizaguirre
, et al.
·
Journal of Clinical Oncology
A scalp cooling system designed to prevent chemotherapy-induced alopecia: Our experience with implementation at a Spanish public hospital.
2016
·
Esther Millastre
, Irene Torres Ramon
, et al.
·
Journal of Clinical Oncology
P-0083 Experience from Miguel Servet University Hospital (Zaragoza, Spain) on Treatment of Hepatocarcinoma: a Retrospective Study
2012
·
Ana Cebollero
, Lourdes Calera
, et al.
·
Annals of Oncology
Nuevos enfoques terapéuticos en cáncer de tiroides
2010
·
Javier Martínez‐Trufero
, Irene Gil Arnaiz
, et al.
·
Revisiones en cáncer
1100 Peripheral blood lymphocite populations in advanced gastric cancer patients have predictive and prognostic value
2009
·
R. Pazo Cid
, J. Lao Romera
, et al.
·
European Journal of Cancer Supplements
Show more works
View as search
Works count:
16
Citation count:
251
H-index:
4
I10-index:
3
Year
Topic
Type